SLC19A1 and cancer: Considering that cancer stemness is involved in oncogenic dedifferentiation via multiple pathways, including regulation of methylation status, SLC19A1 promoter methylation levels were examined and found to be significantly correlated with the abundance of cytotoxic T lymphocytes (CTLs) predicted in several cancer types (Figure 3B).